Skip Navigation



Cardiovascular Research Advance Access [Accepted Manuscript] published online on January 14, 2008

Cardiovascular Research, doi:10.1093/cvr/cvn011
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
78/1/26    most recent
cvn011v2
cvn011v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Knuefermann, P.
Right arrow Articles by Meyer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knuefermann, P.
Right arrow Articles by Meyer, R.
Related Collections
Right arrowRelated Article
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: Role of Toll-like receptor 9

Pascal Knuefermann, MD1,*,, Markus Schwederski, PhD1,*, Markus Velten, MD1, Peter Krings, MD1, Heidi Ehrentraut, PhD1, Myriam Rüdiger2, Olaf Boehm, MD1, Klaus Fink, MD3, Ulrike Dreiner, MD2, Christian Grohé, MD5, Andreas Hoeft, MD1, Georg Baumgarten, MD1, Alexander Koch, MD4, Kai Zacharowski, MD PhD4 and Rainer Meyer, PhD2

1 Department for Anesthesiology and Intensive Care Medicine, University Hospital Bonn, Germany
2 Institute of Physiology II, University Hospital Bonn, Germany
3 Department of Pharmacology and Toxicology, University Hospital Bonn, Germany
4 Molecular Cardioprotection & Inflammation Group, Department of Anaesthesia, Bristol Royal Infirmary, Bristol, UK
5 Department of Internal Medicine, University Hospital Bonn, Germany

Corresponding author: Pascal Knuefermann, MD Department for Anesthesiology and Intensive Care Medicine University Hospital Bonn Sigmund-Freud-Strasse 25, 53105 Bonn, Germany phone: 49-228-2871-4110; FAX: 49-228-2871-4115 E-Mail: Pascal.Knuefermann{at}ukb.uni-bonn.de

Aim: Myocardial function is severely compromised during sepsis. Several underlying mechanisms have been proposed. The innate immune system, i.e. Toll-like receptor (TLR) 2 and 4, significantly contributes to cardiac dysfunction. Little is known regarding TLR9 and its pathogenic ligand bacterial DNA in the myocardium. We therefore studied the role of TLR9 in myocardial inflammation and cardiac contractility.

Methods: Wild-type (WT, C57BL/6) and TLR9-deficient (TLR9-D) mice and isolated cardiomyocytes were challenged with synthetic bacterial DNA (CpG-ODN). Myocardial contractility as well as markers of inflammation/signalling were determined.

Results: Isolated cardiomyocytes incorporated fluorescence-marked CpG-ODN. In WT mice, CpG-ODN caused a robust response in hearts demonstrated by increased levels of tumour necrosis factor (TNF-{alpha}), interleukin (IL)-1β, IL-6, inducible nitric oxide synthase (iNOS), and nuclear factor {kappa}B activity. This inflammatory response was absent in TLR9-D mice. Under similar conditions, contractility measurements of isolated ventricular cardiomyocytes demonstrated a TLR9-dependent loss of sarcomeric shortening after CpG-ODN exposure. This observation was iNOS dependent as the application of a specific iNOS inhibitor reversed sarcomeric shortening to normal levels.

Conclusion: Our data suggest that bacterial DNA contributes to myocardial cytokine production and loss of cardiomyocyte contractility via TLR9.

KEYWORDS sepsis; contractile function; infection/inflammation; cell culture/isolation; cardiomyocytes


Time for primary review: 24

* These two authors contributed equally to this work


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Article

Toll-like receptors and myocardial contractile dysfunction
Toshiyuki Takahashi
Cardiovasc Res 2008 78: 3-4. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Takahashi
Toll-like receptors and myocardial contractile dysfunction
Cardiovasc Res, April 1, 2008; 78(1): 3 - 4.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.